Clinical trial
A Pilot, Controlled, Comparative and Single Blinded Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines Administered Intradermally Using Microneedle Injectors as Compared With Standard Dose Intramuscular Flu Vaccines as Reference.
NCT00558649 is registered in ClinicalTrials.gov with NanoPass Technologies Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot, Controlled, Comparative and Single Blinded Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines Administered Intradermally Using Microneedle Injectors as Compared With Standard Dose Intramuscular Flu Vaccines as Reference.
- Lead sponsor
- NanoPass Technologies Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- December 31, 2007
- Enrollment
- 180 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.